Similar articles

• [Antibody prevalence for hepatitis C and other parenterally transmissible viral diseases in i. v. drug dependent patients].

  Neuwald C, Pont J, Tomasits J, Bauer K. Neuwald C, et al. Acta Med Austriaca. 1992;19(2):47-8. Acta Med Austriaca. 1992. PMID: 1324551 German.
• [Hepatitis C antibodies in non-A, non-B hepatitis patients and members of HIV risk groups (pilot study)].

  Kühnl P, Roggendorf M, Stangel W, Seidl S, Laufs R, Sibrowski W, Bornhövd K, Polywka S, Kalmar G, Deinhardt F, et al. Kühnl P, et al. Beitr Infusionsther. 1990;26:30-2. Beitr Infusionsther. 1990. PMID: 1703858 Clinical Trial. German.
• Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.

  Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G. Babudieri S, et al. J Med Virol. 2005 Jul;76(3):311-7. doi: 10.1002/jmv.20375. J Med Virol. 2005. PMID: 15902712
• Substance abuse, HIV-1 and hepatitis.

  Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, Wigdahl B. Parikh N, et al. Curr HIV Res. 2012 Oct;10(7):557-71. doi: 10.2174/157016212803306023. Curr HIV Res. 2012. PMID: 22973853 Free PMC article. Review.
• The epidemiology of antibody to hepatitis C in Egypt.

  Hibbs RG, Corwin AL, Hassan NF, Kamel M, Darwish M, Edelman R, Constantine NT, Rao MR, Khalifa AS, Mokhtar S, et al. Hibbs RG, et al. J Infect Dis. 1993 Sep;168(3):789-90. doi: 10.1093/infdis/168.3.789. J Infect Dis. 1993. PMID: 8394867 Review. No abstract available.